You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Monoclonal gammopathy of undetermined significance (MGUS)

Showing 1 - 25 of 6,145
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Peripheral Neuropathy, Monoclonal Gammopathy of Undetermined Significance Trial in Washington (Daratumumab and

Not yet recruiting
  • Peripheral Neuropathy
  • Monoclonal Gammopathy of Undetermined Significance
  • Daratumumab and hyaluronidase-fihj
  • Washington, District of Columbia
    Lombardi Comprehensive Cancer Center, Georgetown University
Sep 14, 2023

Monoclonal Gammopathy of Undetermined Significance (MGUS), Smoldering Multiple Myeloma (SMM) Trial (Linvoseltamab)

Not yet recruiting
  • Monoclonal Gammopathy of Undetermined Significance (MGUS)
  • Smoldering Multiple Myeloma (SMM)
  • (no location specified)
Nov 17, 2023

Study in Monoclonal Gammopathy of Undetermined Significance

Not yet recruiting
  • MGUS
    • Oxford, Oxfordshire, United Kingdom
      Secure Study
    Sep 9, 2022

    Multiple Myeloma, Monoclonal Gammopathy of Undetermined Significance Trial in United States (Whole Foods Plant-based Diet, Algae

    Recruiting
    • Multiple Myeloma
    • Monoclonal Gammopathy of Undetermined Significance
    • Whole Foods Plant-based Diet
    • +2 more
    • Basking Ridge, New Jersey
    • +6 more
    Jan 3, 2023

    Prostate Cancer, Multiple Myeloma, Smoldering Multiple Myeloma (SMM) Trial in Rochester (Curcumin plus Piperine)

    Recruiting
    • Prostate Cancer
    • +3 more
    • Curcumin plus Piperine
    • Rochester, New York
      University of Rochester
    Jun 17, 2022

    Monoclonal Gammopathy of Undetermined Significance, Smoldering Multiple Myeloma Trial in United States (Plant based meals)

    Recruiting
    • Monoclonal Gammopathy of Undetermined Significance
    • Smoldering Multiple Myeloma
    • Plant based meals
    • Basking Ridge, New Jersey
    • +6 more
    Apr 11, 2022

    A Cohort Study of Plasma Cell Disorders (PCDs) in PKUFH

    Recruiting
    • Multiple Myeloma
    • +11 more
    • No intervention
    • Beijing, China
      Peking University First Hospital
    Apr 21, 2022

    MGUS, SMM, and MM Patient Experience With Coronavirus 19 Survey

    Recruiting
    • Multiple Myeloma
    • +3 more
    • Questionnaire
    • Lehi, Utah
      HealthTree.org (Online)
    Aug 2, 2021

    Project in First-degree Relatives of Myeloma Patient - The

    Recruiting
    • Multiple Myeloma
    • Monoclonal Gammopathy of Undetermined Significance
    • Sample of Blood
    • Shanghai, Shanghai, China
      Zhongshan Hospital，Fudan University
    Jul 31, 2023

    MGUS, Smoldering Myeloma, Early MDS and CLL to Assess Molecular

    Recruiting
    • Monoclonal Gammopathy of Undetermined Significance (MGUS)
    • +8 more
      • Boston, Massachusetts
      • +6 more
      Apr 14, 2022

      Monoclonal Gammopathy of Undetermined Significance and

      Terminated
      • Smoldering Myeloma
      • Monoclonal Gammopathy of Undetermined Significance
        • Bethesda, Maryland
          National Institutes of Health Clinical Center, 9000 Rockville Pi
        Mar 4, 2021

        Natural History of MGUS in Patients Undergoing Weight Reduction

        Recruiting
        • Monoclonal Gammopathy of Undetermined Significance
          • Indianapolis, Indiana
            Indiana University Simon Cancer Center
          Jun 23, 2021

          Monoclonal Gammopathy, Smoldering Multiple Myeloma Trial in United States (Daratumumab)

          Active, not recruiting
          • Monoclonal Gammopathy
          • Smoldering Multiple Myeloma
          • Monterey, California
          • +5 more
          Nov 1, 2021

          Monoclonal Gammopathy of Uncertain Significance Trial in Utrecht (Zanubrutinib Oral Product)

          Not yet recruiting
          • Monoclonal Gammopathy of Uncertain Significance
          • Zanubrutinib Oral Product
          • Utrecht, Netherlands
            University Medical Center Utrecht
          Jul 6, 2023

          Monoclonal Gammopathy of Undetermined Significance, Smoldering Multiple Myeloma Trial in United States (Metformin XR, Placebo)

          Recruiting
          • Monoclonal Gammopathy of Undetermined Significance
          • Smoldering Multiple Myeloma
          • Metformin XR
          • Placebo
          • Boston, Massachusetts
          • +6 more
          Oct 3, 2022

          Quality of Life in Asymptomatic Monoclonal Gammopathies

          Recruiting
          • Monoclonal Gammopathy of Undetermined Significance
          • Smoldering Plasma Cell Myeloma
          • Quality-of-Life Assessment
          • Questionnaire Administration
          • Houston, Texas
            M D Anderson Cancer Center
          Oct 25, 2022

          Monoclonal Gammopathy Trial in New York, Philadelphia (Isatuximab)

          Recruiting
          • Monoclonal Gammopathy
          • Boston, Massachusetts
          • +1 more
          Nov 16, 2022

          Gene Expression Profile of Bone Marrow Plasma Cells From MGUS

          Terminated
          • Monoclonal Gammopathy of Undetermined Significance
          • Smoldering Myeloma
          • Genetic study of DNA copies
          • Rennes, Bretagne, France
          • +26 more
          Apr 13, 2021

          MRD and Clonal Evolution in Waldenström's Macroglobulinemia and

          Active, not recruiting
          • Waldenstrom Macroglobulinemia
          • MRD and clonal evolution
          • Milano, MI, Italy
          • +13 more
          Nov 2, 2022

          Multiple Myeloma, Monoclonal Gammopathy of Undetermined Significance, Smoldering Multiple Myeloma Trial in Cleveland (Multiple

          Not yet recruiting
          • Multiple Myeloma
          • +2 more
          • Multiple Myeloma M-Protein Analysis
          • Multiple Myeloma Knowledge Questionnaires
          • Cleveland, Ohio
            Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Ca
          Apr 26, 2023

          The Development and Pilot Testing ofNew MR Imaging Protocol to

          Completed
          • Myeloma
          • +2 more
          • Diffusion Weighted Magnetic Resonance Imaging (DWMRI)
          • +2 more
          • Oxford, Oxfordshire, United Kingdom
            Churchill Hospital
          Feb 4, 2021

          Monoclonal Gammopathy of Undetermined Significance Trial in Reykjavík (Clinical follow-up 1, Mental Health and Quality of Life

          Active, not recruiting
          • Monoclonal Gammopathy of Undetermined Significance
          • Clinical follow-up 1
          • +5 more
          • Reykjavík, Iceland
            University of Iceland
          Feb 28, 2022

          Unravel MGUS (Monoclonal Gammopathy of Unknown Significance)

          Active, not recruiting
          • Monoclonal Gammopathy of Unknown Significance
          • Blood sample taken
          • +2 more
          • Reading, Berkshire, United Kingdom
          • +8 more
          Sep 1, 2020

          Screening to Improve Survival in AL Amyloidosis

          Recruiting
          • Smoldering Multiple Myeloma
          • Monoclonal Gammopathy of Undetermined Significance
            • Orange, California
            • +5 more
            Nov 16, 2022

            Multiple Myeloma, Monoclonal Gammopathy of Renal Significance Trial in United States (Cyclophosphamide, Bortezomib,

            Recruiting
            • Multiple Myeloma
            • Monoclonal Gammopathy of Renal Significance
            • Basking Ridge, New Jersey
            • +6 more
            Oct 16, 2023